Parnell Pharmaceuticals Holdings Ltd Share Price Other OTC
Equities
PARNF
AU0000XINEU9
Pharmaceuticals
Sales 2020 | 30M 19.69M 1.57B | Sales 2021 | 34.17M 22.42M 1.79B | Capitalization | 4.08K 2.68K 214K |
---|---|---|---|---|---|
Net income 2020 | -15M -9.85M -786M | Net income 2021 | -1M -656K -52.38M | EV / Sales 2020 | 2.18 x |
Net Debt 2020 | 56.16M 36.86M 2.94B | Net Debt 2021 | 58.89M 38.65M 3.08B | EV / Sales 2021 | 1.72 x |
P/E ratio 2020 |
-0.56
x | P/E ratio 2021 |
-
| Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 31/01/10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/20 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 20/12/20 |
1st Jan change | Capi. | |
---|---|---|
-19.73% | 72.39B | |
-11.01% | 6.54B | |
+15.88% | 3.43B | |
-2.50% | 3.12B | |
+0.84% | 1.4B | |
-17.27% | 1.34B | |
-4.10% | 1.26B | |
-28.16% | 1.2B | |
-14.67% | 1.12B |